IBA1 identifies tumour‐associated macrophages at the invasive front of malignant melanoma
Histopathology · 16.11.2026
DOI: 10.1111/his.70301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 16.11.2026. Verfasst von Isaac T Ng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Toxicology, School of Biomedical Sciences, The University of Western Australia, Nedlands, Western Australia, Australia. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Council of Western Australia, Australian Research Training Program, University of Western Australia.
Abstract (Originalsprache)
Although CD68 is widely used as a clinical pan‐macrophage marker, its sensitivity and specificity for identifying macrophage populations are inconsistent. Consequently, reports on the role of macrophages in primary melanoma outcomes have been conflicting.
Aims
To evaluate the sensitivity of ionised calcium‐binding adaptor molecule 1 ( IBA1) compared with CD68 for identifying tumour‐associated macrophages ( TAMs ) in primary melanoma, and to assess the distribution and clinical relevance of TAMs . Methods and results Human melanoma samples from the Western Australian Melanoma Health Study ( WAMHS ) were analysed using multiplex immunofluorescence to compare IBA1 and CD68 staining. IBA1 was more sensitive than CD68 for detecting TAMs , revealing an increased apparent TAM density. TAMs were abundant across melanomas of all thicknesses and were predominantly localised to tumour margins. However, TAM density was not associated with melanoma‐specific survival.
Conclusions
IBA1 is a sensitive and reliable pan‐macrophage marker for quantifying TAM abundance and distribution in melanoma. Despite their abundance at tumour margins, total TAM density does not predict survival, highlighting the need to further investigate their functional roles in tumour progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacology and Toxicology, School of Biomedical Sciences, The University of Western Australia, Nedlands, Western Australia, Australia.
- The Olivia Newton John Cancer Research Institute, Melbourne, Victoria, Australia.
- Medical School, The University of Western Australia, Nedlands, Western Australia, Australia.
- Department of Anatomical Pathology, PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.
- Institute for Respiratory Health, University of Western Australia, Nedlands, Western Australia, Australia.
- Melanoma Discovery Laboratory, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia.
ORCID-Profile: Isaac T Ng, Michael W Murrey, Sarah V Ward, Nima Mesbah Ardakani, Elizabeth A Nathan, Nathan T Harvey, Jason Waithman, Steven E Mutsaers, Peter K H Lau, Fiona J Pixley
Förderung
- Cancer Council of Western Australia
- Australian Research Training Program
- University of Western Australia
- Department of Health, Government of Western Australia
- Raine Medical Research Foundation
Zitieren
APA
Ng, I. T., Murrey, M. W., Ward, S. V., Ardakani, N. M., Nathan, E. A., Harvey, N. T., Waithman, J., Mutsaers, S. E., Lau, P. K. H., & Pixley, F. J. (2026). IBA1 identifies tumour‐associated macrophages at the invasive front of malignant melanoma. Histopathology. https://doi.org/10.1111/his.70301
Vancouver
Ng IT, Murrey MW, Ward SV, Ardakani NM, Nathan EA, Harvey NT, et al. IBA1 identifies tumour‐associated macrophages at the invasive front of malignant melanoma. Histopathology. 2026. doi:10.1111/his.70301
BibTeX
@article{Ng2026,
author = {Ng, Isaac T and Murrey, Michael W and Ward, Sarah V and Ardakani, Nima Mesbah and Nathan, Elizabeth A and Harvey, Nathan T and Waithman, Jason and Mutsaers, Steven E and Lau, Peter K H and Pixley, Fiona J},
title = {IBA1 identifies tumour‐associated macrophages at the invasive front of malignant melanoma},
journal = {Histopathology},
year = {2026},
doi = {10.1111/his.70301}
}
EUVIMED